Recent

% | $
Quotes you view appear here for quick access.

pSivida Corp. Message Board

  • mickmack50 mickmack50 Feb 15, 2013 10:27 AM Flag

    Projected Revenues

    Iluvien alone, based on Alimera's 2017 estimate, is around 400Mill. That would be Europe alone. If we could use those numbers, and use the 14% of net sales forwarded to PSDV(at no costs to us), then we are talking 56 million in revenues in Europe alone. Not to mention potential for US approval of Iluvien for chronic DME and/or Uveitis insert approval. For those who have owned stock in PSDV through the years, the waiting is just about over. As Len Zehr wrote in a SA article years back "we are on the cusp" of a breakthrough. Should be an interest ing balance of 2013. GLTA

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Mick:
      Plenty of speculation as to the pop in PPS going on by newbies, shorts and of course us longs. I view Ashton's presentation last week as a major confidence booster in this little gem. Have to believe we are no longer flying under the radar and the smart money is jumping on board. Glad to see all the freaks coming out- usually a sign of good things about to happen. If I were to take a guess as to the catalyst for today's movement I would have to think it is Illuvien related. Even though Ashton has indicated in previous conference calls that PSDV is a takeover target- I seriously doubt that is going to happen at this time. Just happy to see a nice pop with more to come. Good luck buddy.

    • I don't understand where you got the 14% number on net sales while pSivida reports 20% on net profits on their website. Net sales and net profits will be very different numbers.

 
PSDV
3.79-0.01(-0.26%)Jul 2 4:00 PMEDT